Psychiatry Research: Neuroimaging
Volume 148, Issue 2 , Pages 111-120 , 1 December 2006

Single voxel proton magnetic resonance spectroscopy in post-stroke depression

  • Lidia Glodzik-Sobanska

      Affiliations

    • Center for Brain Health, New York University School of Medicine, New York, NY 10016, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 212 263 1091; fax: +1 212 263 3270.
    • ,
  • Agnieszka Slowik

      Affiliations

    • Department of Neurology, Institute of Neurology, Jagiellonian University, Krakow, Poland
    • ,
  • Pauline McHugh

      Affiliations

    • Center for Brain Health, New York University School of Medicine, New York, NY 10016, USA
    • ,
  • Barbara Sobiecka

      Affiliations

    • Department of Radiology, Jagiellonian University, Krakow, Poland
    • ,
  • Justyna Kozub

      Affiliations

    • Department of Radiology, Jagiellonian University, Krakow, Poland
    • ,
  • Kenneth E. Rich

      Affiliations

    • Center for Brain Health, New York University School of Medicine, New York, NY 10016, USA
    • ,
  • Andrzej Urbanik

      Affiliations

    • Department of Radiology, Jagiellonian University, Krakow, Poland
    • ,
  • Andrzej Szczudlik

      Affiliations

    • Department of Neurology, Institute of Neurology, Jagiellonian University, Krakow, Poland

Received 21 March 2006 ,Revised 6 July 2006 ,Accepted 27 August 2006.

References 

  1. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders. 4th ed.. Washington, DC: American Psychiatric Press; 1994;
  2. Andersen G, Vestergaard K, Riis JQ, Lauritzen L. Incidence of post-stroke depression during the first year in a large unselected stroke population determined using a valid standardized rating scale. Acta Psychiatrica Scandinavica. 1994;90:190–195
  3. Andersen G, Vestergaard K, Ingemann-Nielsen M, Lauritzen L. Risk factors for post-stroke depression. Acta Psychiatrica Scandinavica. 1995;92:193–198
  4. Astrom M, Adolfsson R, Asplund K. Major depression in stroke patients a 3-year longitudinal study. Stroke. 1993;24:976–982
  5. Astrom M, Olsson T, Asplund K. Different linkage of depression to hypercortisolism early versus late after stroke. Stroke. 1993;24:52–57
  6. Auer DP, Putz B, Kraft E, Lipinski B, Schill J, Holsboer F. Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study. Biological Psychiatry. 2000;47:305–313
  7. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet. 1991;337:1521–1526
  8. Beauregard M, Leroux JM, Bergman S, Arzoumanian Y, Beaudoin G, Bourgouin P. The functional neuroanatomy of major depression: an fMRI study using an emotional activation paradigm. NeuroReport. 1998;9:3253–3258
  9. Binesh N, Kumar A, Hwang S, Mintz J, Thomas MA. Neurochemistry of late-life major depression: a pilot two-dimensional MR spectroscopic study. Journal of Magnetic Resonance Imaging. 2004;20:1039–1045
  10. Bottomley PA. Spatial localization in NMR spectroscopy in vivo. Annals of the New York Academy of Science. 1987;508:333–348
  11. Brambilla P, Stanley JA, Nicoletti MA, Sassi RB, Mallinger AG, Frank E, et al. 1H Magnetic resonance spectroscopy study of dorsolateral prefrontal cortex in unipolar mood disorder patients. Psychiatry Research. Neuroimaging. 2005;138:131–139
  12. Carson AJ, MacHale S, Allen K, Lewrie SM, Dennis M, House A, et al. Depression after stroke and lesion location: a systematic review. Lancet. 2002;356:122–126
  13. Chemerinski E, Robinson RG. The neuropsychiatry of stroke. Psychosomatics. 2000;41:5–13
  14. Dennis M, O'Rourke S, Lewis S, Sharpe M, Warlow C. Emotional outcomes after stroke: factors associated with poor outcome. Journal of Neurology, Neurosurgery and Psychiatry. 2000;68:47–52
  15. Gainotti G. Reply: Psychological model of post-stroke major depression. British Journal of Psychiatry. 2000;176:259
  16. Goddard AW, Mason GF, Appel M, Rothman DL, Gueorguieva R, Behar KL, et al. Impaired GABA neuronal response to acute benzodiazepine administration in panic disorder. American Journal of Psychiatry. 2004;161:2186–2193
  17. Gouliaev AH, Senning A. Piracetam and other structurally related nootropics. Brain Research Reviews. 1994;19:180–222
  18. Gresham GE, Philips TF, Wolf PA, McNamara PM, Kannel WB, Dawber TR. Epidemiologic profile of long-term stroke disability: the Framingham study. Archives of Physical Medicine and Rehabilitation. 1979;60:487–491
  19. Gruber S, Frey R, Mlynárik V, Stadlbauer A, Heiden A, Kasper S, et al. Quantification of metabolic differences in the frontal brain of depressive patients and controls obtained by 1H-MRS at 3 Tesla. Investigative Radiology. 2003;38:403–408
  20. Hamilton M. A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry. 1960;23:56–62
  21. Haase A, Frahm J, Hänicke W, Matthaei D. 1H NMR chemical shift selective (CHESS) imaging. Physics in Medicine and Biology. 1985;30:341–344
  22. Jorm AF, Jacomb PA. The Informant questionnaire on cognitive decline in the elderly (IQCODE): socio-demographic correlates, reliability, validity and some norms. Psychological Medicine. 1989;19:1015–1022
  23. Kauhanen ML, Korpelainen JT, Hiltunen P, Brusin E, Mononen H, Maatta R, et al. Poststroke depression correlates with cognitive impairment and neurological deficits. Stroke. 1999;30:1875–1880
  24. Kimbrell TA, Ketter TA, George MS, Little JT, Benson BE, Willis MW, et al. Regional cerebral glucose utilization in patients with a range of severities of unipolar depression. Biological Psychiatry. 2002;51:237–252
  25. Krystal JH, Sanacora G, Blumberg H, Anand H, Charney DS, Marek G, et al. Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments.. Molecular Psychiatry. 2002;7(Suppl 1):S71–S80
  26. Kumar A, Jin Z, Biler W, Udupa J, Gottlieb G. Late-onset minor and major depression: early evidence for common neuroanatomical substrates detected by using MRI. Proceedings of the National Academy of Sciences of the United States of America. 1998;95:7654–7658
  27. Kumar A, Thomas A, Lavretsky H, Yue K, Huda A, Curran J, et al. Frontal white matter biochemical abnormalities in late-life major depression detected with proton magnetic resonance spectroscopy. American Journal of Psychiatry. 2002;159:630–636
  28. Labelle M, Khiat A, Durocher A, Boulanger Y. Comparison of metabolite levels and water diffusion between cortical and subcortical strokes as monitored by MRI and MRS. Investigative Radiology. 2001;36:155–163
  29. Levine J, Panchalingam K, Rapoport A, Gershon S, McClure RJ, Pettegrew JW. Increased cerebrospinal fluid glutamine levels in depressed patients. Biological Psychiatry. 2000;47:586–593
  30. Malhi GS, Valenzuela M, Wen W, Sachdev S. Magnetic resonance spectroscopy and its applications in psychiatry. Australian and New Zealand Journal of Psychiatry. 2002;36:31–43
  31. Malec JF, Richardson JW, Sinaki M, O'Brein MW. Types of affective response to stroke. Archives of Physical Medicine and Rehabilitation. 1990;71:279–284
  32. Michael N, Erfurth A, Ohrmann P, Arolt V, Heindel W, Pfleiderer B. Metabolic changes within the left dorsolateral prefrontal cortex occurring with electroconvulsive therapy in patients with treatment resistant unipolar depression. Psychological Medicine. 2003;33:1277–1284
  33. Michael-Titus T, Bains S, Jeetle J, Whelpton R. Imipramine and phenelzine decrease glutamate overflow in the prefrontal cortex-a possible mechanism of neuroprotection in major depression?. Neuroscience. 2000;100:681–684
  34. Mitani H, Shirayama Y, Yamada T, Maeda K, Ashby CR, Kawahara R. Correlation between plasma levels of glutamate, alanine and serine with severity of depression. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 2006;30:1155–1158
  35. Moghaddam B. Stress activation of glutamate neurotransmission in the prefrontal cortex: implications for dopamine-associated psychiatric disorders. Biological Psychiatry. 2002;51:775–787
  36. Murata T, Kimura H, Omori M, Kado H, Kosaka H, Bidaka T, et al. MRI white matter hyperintensities, 1H-MR spectroscopy and cognitive function in geriatric depression: a comparison of early and late-onset cases. International Journal of Geriatric Psychiatry. 2001;16:1129–1135
  37. Nowak G, Ordway GA, Paul IA. Alterations in the N-methyl-d-aspartate (NMDA) receptor complex in the frontal cortex of suicide victims. Brain Research. 1995;675:157–164
  38. Pfleiderer B, Michael N, Erfurth A, Ohrmann P, Hohmann U, Wolgast M, et al. Effective electroconvulsive therapy reverses glutamate/glutamine deficit in the left anterior cingulum of unipolar depressed patients. Psychiatry Research. Neuroimaging. 2003;122:185–192
  39. Petroff OAC, Pleban LS, Spencer DD. Symbiosis between in vivo and in vitro NMR spectroscopy: the creatine, n-acetylaspartate, glutamate, and GABA content of the epileptic human brain. Magnetic Resonance Imaging. 1995;13:1197–1211
  40. Reynolds IJ, Miller RJ. Tricyclic antidepressants block N-methyl-d-aspartate receptors: similarities to the action of zinc. British Journal of Pharmacology. 1998;95:95–102
  41. Robinson RG, Starr LB, Kubos KL, Price TR. A two-year longitudinal study of post-stroke mood disorders: findings during the initial evaluation. Stroke. 1983;14:726–740
  42. Rosenberg DR, Mirza Y, Russell A, Tang J, Smith JM, Banerjee SP, et al. Reduced anterior cingulate glutamatergic concentrations in childhood ocd and major depression versus healthy controls. American Journal of Academic Child and Adolescent Psychiatry. 2004;43:1146–1153
  43. Rosenberg DR, MacMaster FP, Mirza Y, Smith JM, Easter PC, Banerjee BP, et al. Reduced anterior cingulate glutamate in pediatric major depression: a magnetic resonance spectroscopy study. Biological Psychiatry. 2005;58:700–704
  44. Rowland LM, Bustillo JR, Mullins PG, Jung RE, Lenroot R, Landgraf E, et al. Effects of ketamine on anterior cingulate glutamate metabolism in healthy humans: a 4-T proton MRS study. American Journal of Psychiatry. 2005;162:394–396
  45. Sanacora G, Gueorguieva R, Epperson N, Wu YT, Appel M, Rothman D, et al. Subtype-specyfic alteraltions of gamma-aminobutyric acid and glutamate in patients with major depression. Archives of General Psychiatry. 2004;61:705–713
  46. Sappey-Marinier D, Calabrese G, Hetherington HP, Fisher SN, Deicken R, Van Dyke C, et al. Proton magnetic resonance spectroscopy of human brain: applications to normal white matter, chronic infarction, and MRI white matter signal hyperintensities. Magnetic Resonanace in Medicine. 1992;26:313–327
  47. Scandinavian Stroke Study Group. Multicenter trial of hemodilution in ischemic stroke-background and study protocol. Stroke. 1985;16:885–890
  48. Schubert F, Gallinat J, Seifert F, Rinneberg H. Glutamate concentrations in human brain using single voxel proton magnetic resonance spectroscopy at 3 Tesla. Neuroimage. 2004;21:1762–1771
  49. Singh A, Black SE, Herrmann N, Leibovitch FS, Ebert PL, Lawrence J, et al. Functional and neuroanatomical correlations in poststroke depression: the Sunnybrook Stroke Study. Stroke. 2000;31:637–644
  50. Soares JC, Mann JJ. The anatomy of mood disorders-review of structural neuroimaging studies. Biological Psychiatry. 1997;41:86–106
  51. Soher BJ, Vermathen P, Schuff N, Wiedermann D, Meyerhoff DJ, Weiner MW, et al. Short TE in vivo H MR spectroscopic imaging at 1,5 T: acquisition and automated spectral analysis. Magnetic Resonance Imaging. 2000;18:1159–1165
  52. Spencer KA, Tompkins CA, Schulz R. Assessment of depression in patients with brain pathology: the case of stroke. Psychological Bulletin. 1997;22:132–152
  53. van Praag HM. Can stress cause depression?. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 2004;28:891–907
  54. Webb PG, Sailasuta N, Kohler SJ, Raidy T, Moats RA, Hurd E. Automated single-voxel proton MRS: technical development and multisite verification. Magnetic Resonance in Medicine. 1994;31:365–373
  55. Whyte EM, Mulsant BH. Post stroke depression: epidemiology, pathophysiology, and biological treatment. Biological Psychiatry. 2002;52:253–264

PII: S0925-4927(06)00128-4

doi: 10.1016/j.pscychresns.2006.08.004

Psychiatry Research: Neuroimaging
Volume 148, Issue 2 , Pages 111-120 , 1 December 2006

Article Tools

* Image Usage & Resolution